Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report.

about

Osteonecrosis after intranasal injection with bevacizumab in treating hereditary hemorrhagic telangiectasia: A case report.

Item

http://www.wikidata.org/entity/Q48187031

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Osteonecrosis after intranasal ...... telangiectasia: A case report.

@en

Osteonecrosis after intranasal ...... telangiectasia: A case report.

@nl

type

Item

label

Osteonecrosis after intranasal ...... telangiectasia: A case report.

@en

Osteonecrosis after intranasal ...... telangiectasia: A case report.

@nl

prefLabel

Osteonecrosis after intranasal ...... telangiectasia: A case report.

@en

Osteonecrosis after intranasal ...... telangiectasia: A case report.

@nl

P1476

Osteonecrosis after intranasal ...... telangiectasia: A case report.

@en

P2093

Else Merckoll

http://www.w3.org/2001/XMLSchema#string

Erik Fink Eriksen

http://www.w3.org/2001/XMLSchema#string

John Magnar Slåstad

http://www.w3.org/2001/XMLSchema#string

Sinan Dheyauldeen

http://www.w3.org/2001/XMLSchema#string

P2860

Bone marrow lesions in hip osteoarthritis are characterized by increased bone turnover and enhanced angiogenesis.

Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials.

Bone marrow lesions: a universal bone response to injury?

Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose.

Systemic pharmacokinetics following intravitreal injections of ranibizumab, bevacizumab or aflibercept in patients with neovascular AMD

Bevacizumab-associated osteonecrosis of the wrist and knee in three pediatric patients with recurrent CNS tumors.

Safety of intranasal Bevacizumab (Avastin) treatment in patients with hereditary hemorrhagic telangiectasia-associated epistaxis.

Osteonecrosis of the mandible associated with bevacizumab therapy.

P304

593-596

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/LARY.26722

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P50

Ketil R. Heimdal

Johan Steineger

P577

2017-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28671294

http://www.w3.org/2001/XMLSchema#string

P921

bevacizumab

hereditary hemorrhagic telangiectasia